This second ISPOR PerfO Task Force report focuses on clinical trial implementation considerations that are especially relevant to PerfO assessments, when compared to other clinical outcome assessment types.
E. Bush, Chris J. Edgar, Heather R. Adams et al.· Value in Health· 0 citations
Recommendations are made regarding necessary literature reviews, including qualitative data and related conceptual models, disease models including pathophysiology and neuropsychological profile, and clinical outcome assessment (COA) reviews, including content validity, psychometrics, and fitness-for-purpose.
Chris J. Edgar, Kathleen L. Poston, Cheryl D. Coon et al.· Journal of Parkinson's Disea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.